The Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report contains detailed information on the respiratory syncytial virus (rsv) infection drug pipeline. This report provides insight into the pipeline status of respiratory syncytial virus (rsv) infection drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date. In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.Key benefits' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas. ' Keep track of your competitors and partners by better understanding their product pipeline. ' Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas. ' Maintain a critical competitive advantage.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline
Report
Published on November 2010
Report Summary
The Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report contains detailed information on the respiratory
syncytial virus (rsv) infection drug pipeline. This report provides insight into the pipeline status of respiratory syncytial virus (rsv)
infection drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by
stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular
format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical
trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of
development and the top 20 companies with products in the late stage of development. Finally, each report also provides a
comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy
areas.
' Keep track of your competitors and partners by better understanding their product pipeline.
' Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical
phase for specific disease areas.
' Maintain a critical competitive advantage.
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table of Content
% of Products by Phase of Development
No. of Products by Phase of Development
Marketed Products vs. Pipeline Products
Company Overview - Pipeline Projects
Legend
--Top 5 Companies in Early Stage Respiratory Syncytial Virus (RSV) Infection Products
--Top 5 Companies in Late Stage Respiratory Syncytial Virus (RSV) Infection Products
--Top 5 Companies in Marketed Respiratory Syncytial Virus (RSV) Infection Products
Patent Expirations
Upcoming Milestones
Product Sales
Full Pipeline View
--Product Details : Unknown/Research
--Product Details : Pre Clinical
--Product Details : Phase I
--Product Details : Phase II
--Product Details : Pending Approval
--Product Details : On the Market
News Updates
--Product Updates
--Regulatory
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 495.00 Quantity: _____
Corporate License--USD 3 737.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report Page 4/4